

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.08429724 |
| 2 | glutamate secretion (GO:0014047) | 5.54238178 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.30873949 |
| 4 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.28764071 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.20796381 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.19507130 |
| 7 | glutamate receptor signaling pathway (GO:0007215) | 5.15776068 |
| 8 | vocalization behavior (GO:0071625) | 5.07276757 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.00163115 |
| 10 | protein localization to synapse (GO:0035418) | 4.94121194 |
| 11 | locomotory exploration behavior (GO:0035641) | 4.93612329 |
| 12 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.88721707 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.81686044 |
| 14 | synaptic vesicle maturation (GO:0016188) | 4.81100137 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.77050455 |
| 16 | synaptic transmission, glutamatergic (GO:0035249) | 4.76729655 |
| 17 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.58367257 |
| 18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.47383269 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 4.45965148 |
| 20 | neuron-neuron synaptic transmission (GO:0007270) | 4.39578526 |
| 21 | behavioral response to nicotine (GO:0035095) | 4.35129665 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.32800607 |
| 23 | neuronal action potential propagation (GO:0019227) | 4.28367555 |
| 24 | cellular ketone body metabolic process (GO:0046950) | 4.24935813 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 4.18917683 |
| 26 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.09747304 |
| 27 | long-term memory (GO:0007616) | 4.08690428 |
| 28 | exploration behavior (GO:0035640) | 4.06348622 |
| 29 | positive regulation of synapse maturation (GO:0090129) | 4.04317381 |
| 30 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.95856181 |
| 31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.87238389 |
| 32 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.83141058 |
| 33 | neurotransmitter secretion (GO:0007269) | 3.81742654 |
| 34 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.81352275 |
| 35 | ketone body metabolic process (GO:1902224) | 3.75039852 |
| 36 | long-term synaptic potentiation (GO:0060291) | 3.74880400 |
| 37 | regulation of postsynaptic membrane potential (GO:0060078) | 3.73324287 |
| 38 | regulation of synaptic plasticity (GO:0048167) | 3.71063374 |
| 39 | membrane depolarization during action potential (GO:0086010) | 3.70562209 |
| 40 | neuron recognition (GO:0008038) | 3.70532357 |
| 41 | presynaptic membrane assembly (GO:0097105) | 3.67635975 |
| 42 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.65924506 |
| 43 | regulation of vesicle fusion (GO:0031338) | 3.65094995 |
| 44 | serotonin metabolic process (GO:0042428) | 3.61988241 |
| 45 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.56544022 |
| 46 | positive regulation of membrane potential (GO:0045838) | 3.56154543 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 3.51988964 |
| 48 | negative regulation of amino acid transport (GO:0051956) | 3.50847721 |
| 49 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.50703698 |
| 50 | detection of light stimulus involved in visual perception (GO:0050908) | 3.50703698 |
| 51 | protein polyglutamylation (GO:0018095) | 3.48046872 |
| 52 | regulation of glutamate secretion (GO:0014048) | 3.46195065 |
| 53 | axonal fasciculation (GO:0007413) | 3.45639982 |
| 54 | neuronal action potential (GO:0019228) | 3.45559844 |
| 55 | presynaptic membrane organization (GO:0097090) | 3.45104447 |
| 56 | startle response (GO:0001964) | 3.44112788 |
| 57 | response to histamine (GO:0034776) | 3.43690252 |
| 58 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.41657098 |
| 59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.39930271 |
| 60 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.37082429 |
| 61 | membrane depolarization (GO:0051899) | 3.37080978 |
| 62 | innervation (GO:0060384) | 3.35677927 |
| 63 | postsynaptic membrane organization (GO:0001941) | 3.34584231 |
| 64 | regulation of synapse maturation (GO:0090128) | 3.33410672 |
| 65 | dendrite morphogenesis (GO:0048813) | 3.32971285 |
| 66 | transmission of nerve impulse (GO:0019226) | 3.32846750 |
| 67 | regulation of neurotransmitter secretion (GO:0046928) | 3.31452397 |
| 68 | calcium ion-dependent exocytosis (GO:0017156) | 3.30350604 |
| 69 | cellular potassium ion homeostasis (GO:0030007) | 3.29923253 |
| 70 | behavioral fear response (GO:0001662) | 3.27884867 |
| 71 | behavioral defense response (GO:0002209) | 3.27884867 |
| 72 | neurotransmitter transport (GO:0006836) | 3.25956813 |
| 73 | dendritic spine organization (GO:0097061) | 3.24435892 |
| 74 | L-fucose catabolic process (GO:0042355) | 3.23945577 |
| 75 | fucose catabolic process (GO:0019317) | 3.23945577 |
| 76 | L-fucose metabolic process (GO:0042354) | 3.23945577 |
| 77 | regulation of sarcomere organization (GO:0060297) | 3.22638457 |
| 78 | synaptic vesicle endocytosis (GO:0048488) | 3.22139314 |
| 79 | gamma-aminobutyric acid transport (GO:0015812) | 3.19316672 |
| 80 | sperm motility (GO:0030317) | 3.18787672 |
| 81 | cellular sodium ion homeostasis (GO:0006883) | 3.15484484 |
| 82 | proline transport (GO:0015824) | 3.14948216 |
| 83 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.14939019 |
| 84 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.14939019 |
| 85 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.14939019 |
| 86 | chemosensory behavior (GO:0007635) | 3.14200686 |
| 87 | regulation of synapse structural plasticity (GO:0051823) | 3.14075507 |
| 88 | fear response (GO:0042596) | 3.11715363 |
| 89 | indolalkylamine metabolic process (GO:0006586) | 3.10625580 |
| 90 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.10485606 |
| 91 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.10379153 |
| 92 | indole-containing compound catabolic process (GO:0042436) | 3.10212472 |
| 93 | indolalkylamine catabolic process (GO:0046218) | 3.10212472 |
| 94 | tryptophan catabolic process (GO:0006569) | 3.10212472 |
| 95 | inner ear receptor cell development (GO:0060119) | 3.10130684 |
| 96 | primary amino compound metabolic process (GO:1901160) | 3.08547678 |
| 97 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.08390301 |
| 98 | learning (GO:0007612) | 3.07502385 |
| 99 | reflex (GO:0060004) | 3.07391128 |
| 100 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.06991133 |
| 101 | regulation of synaptic transmission (GO:0050804) | 3.06776549 |
| 102 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.05963033 |
| 103 | detection of calcium ion (GO:0005513) | 3.05035492 |
| 104 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.04765962 |
| 105 | cochlea development (GO:0090102) | 3.03537865 |
| 106 | * synaptic transmission (GO:0007268) | 3.03034677 |
| 107 | positive regulation of fibroblast migration (GO:0010763) | 3.02160087 |
| 108 | calcium ion import (GO:0070509) | 3.01503770 |
| 109 | regulation of neurotransmitter transport (GO:0051588) | 3.01460022 |
| 110 | cerebellar granule cell differentiation (GO:0021707) | 3.01029733 |
| 111 | dopamine biosynthetic process (GO:0042416) | 3.00583026 |
| 112 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.00307998 |
| 113 | regulation of neurotransmitter levels (GO:0001505) | 2.98516840 |
| 114 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.98151046 |
| 115 | cAMP catabolic process (GO:0006198) | 2.96856008 |
| 116 | indole-containing compound metabolic process (GO:0042430) | 2.96733717 |
| 117 | kynurenine metabolic process (GO:0070189) | 2.96555719 |
| 118 | behavioral response to cocaine (GO:0048148) | 2.95664001 |
| 119 | auditory behavior (GO:0031223) | 2.95633380 |
| 120 | establishment of protein localization to Golgi (GO:0072600) | 2.95321830 |
| 121 | acrosome reaction (GO:0007340) | 2.92790100 |
| 122 | social behavior (GO:0035176) | 2.92193469 |
| 123 | intraspecies interaction between organisms (GO:0051703) | 2.92193469 |
| 124 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.91913781 |
| 125 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.91869696 |
| 126 | nephron tubule morphogenesis (GO:0072078) | 2.91481412 |
| 127 | nephron epithelium morphogenesis (GO:0072088) | 2.91481412 |
| 128 | positive regulation of synaptic transmission (GO:0050806) | 2.91389239 |
| 129 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.89273084 |
| 130 | negative regulation of neurotransmitter transport (GO:0051589) | 2.89110245 |
| 131 | insulin secretion (GO:0030073) | 2.88001912 |
| 132 | sleep (GO:0030431) | 2.87914889 |
| 133 | peristalsis (GO:0030432) | 2.86109075 |
| 134 | cyclic nucleotide catabolic process (GO:0009214) | 2.85821652 |
| 135 | neuromuscular synaptic transmission (GO:0007274) | 2.83255614 |
| 136 | response to pheromone (GO:0019236) | 2.79408845 |
| 137 | alanine transport (GO:0032328) | 2.76969496 |
| 138 | musculoskeletal movement (GO:0050881) | 2.76819265 |
| 139 | multicellular organismal movement (GO:0050879) | 2.76819265 |
| 140 | regulation of action potential (GO:0098900) | 2.75455661 |
| 141 | urinary tract smooth muscle contraction (GO:0014848) | 2.72304790 |
| 142 | regulation of neurotransmitter uptake (GO:0051580) | 2.71696811 |
| 143 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.67083149 |
| 144 | signal peptide processing (GO:0006465) | 2.65891802 |
| 145 | spinal cord motor neuron differentiation (GO:0021522) | 2.65310766 |
| 146 | regulation of cilium movement (GO:0003352) | 2.64465340 |
| 147 | renal tubule morphogenesis (GO:0061333) | 2.64033021 |
| 148 | action potential (GO:0001508) | 2.62291814 |
| 149 | protein localization to cilium (GO:0061512) | 2.60051933 |
| 150 | adaptation of signaling pathway (GO:0023058) | 2.59244199 |
| 151 | glycerophospholipid catabolic process (GO:0046475) | 2.59021304 |
| 152 | regulation of glucokinase activity (GO:0033131) | 2.57568394 |
| 153 | regulation of hexokinase activity (GO:1903299) | 2.57568394 |
| 154 | * cellular potassium ion transport (GO:0071804) | 2.54282944 |
| 155 | * potassium ion transmembrane transport (GO:0071805) | 2.54282944 |
| 156 | multicellular organismal signaling (GO:0035637) | 2.54148750 |
| 157 | regulation of female gonad development (GO:2000194) | 2.54136854 |
| 158 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.53870468 |
| 159 | tryptophan metabolic process (GO:0006568) | 2.53141694 |
| 160 | nonmotile primary cilium assembly (GO:0035058) | 2.52276127 |
| 161 | protein targeting to Golgi (GO:0000042) | 2.50728262 |
| 162 | positive regulation of meiosis (GO:0045836) | 2.50047166 |
| 163 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.50031493 |
| 164 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.50031493 |
| 165 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.49848418 |
| 166 | dopamine transport (GO:0015872) | 2.49778850 |
| 167 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.48983735 |
| 168 | multicellular organism reproduction (GO:0032504) | 2.47978959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EZH2_22144423_ChIP-Seq_EOC_Human | 6.03301103 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.30223095 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.08338484 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.03722692 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.98682457 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.95139674 |
| 7 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58095593 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.56408359 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.56408359 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56286749 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55019956 |
| 12 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.54533049 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.45050333 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.44410181 |
| 15 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.38385627 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35382478 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35191545 |
| 18 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30634426 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.16400892 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.15899939 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.14498522 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14079123 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.11901329 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.09169104 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.04334019 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.01808336 |
| 27 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.97684046 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.96628618 |
| 29 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.94383384 |
| 30 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.87484895 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.83425637 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.80180323 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.78012547 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.71919830 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.65226262 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63722710 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57653138 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57512895 |
| 39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.50752055 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.46301793 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.44609586 |
| 42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.43736875 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.43469712 |
| 44 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42257081 |
| 45 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.40486292 |
| 46 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.40190261 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39956734 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39688977 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.38947875 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38495107 |
| 51 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.37803476 |
| 52 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.37033114 |
| 53 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.35844206 |
| 54 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.35844206 |
| 55 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35581593 |
| 56 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.33837605 |
| 57 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31679734 |
| 58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31356207 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29661231 |
| 60 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.28096888 |
| 61 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26707732 |
| 62 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26628639 |
| 63 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26209261 |
| 64 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.26054834 |
| 65 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20274580 |
| 66 | * AR_19668381_ChIP-Seq_PC3_Human | 1.19805687 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18221999 |
| 68 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17887787 |
| 69 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.16774514 |
| 70 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15507544 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15218594 |
| 72 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15164266 |
| 73 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15163252 |
| 74 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14977602 |
| 75 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.14319217 |
| 76 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.13176852 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12666456 |
| 78 | EWS_26573619_Chip-Seq_HEK293_Human | 1.12416445 |
| 79 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12261836 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11593944 |
| 81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11516665 |
| 82 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10843357 |
| 83 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10352239 |
| 84 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09611372 |
| 85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09611372 |
| 86 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07895341 |
| 87 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.07286370 |
| 88 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06692322 |
| 89 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06356074 |
| 90 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06343568 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.06181570 |
| 92 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.06181570 |
| 93 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06059948 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05781988 |
| 95 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05602880 |
| 96 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.05073099 |
| 97 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.04951885 |
| 98 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04654617 |
| 99 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04385038 |
| 100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04301935 |
| 101 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.03679521 |
| 102 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03575760 |
| 103 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03369290 |
| 104 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02708645 |
| 105 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02395818 |
| 106 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01935336 |
| 107 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01420080 |
| 108 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01399844 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01399814 |
| 110 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00714633 |
| 111 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00197918 |
| 112 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00189223 |
| 113 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98758231 |
| 114 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98753530 |
| 115 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97898864 |
| 116 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96518130 |
| 117 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95860765 |
| 118 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95054183 |
| 119 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95046870 |
| 120 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93885769 |
| 121 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92366874 |
| 122 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92311853 |
| 123 | * JUN_21703547_ChIP-Seq_K562_Human | 0.92179175 |
| 124 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.91519547 |
| 125 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90979852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.81230683 |
| 2 | MP0003880_abnormal_central_pattern | 5.09408667 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.07209057 |
| 4 | MP0004270_analgesia | 3.58584329 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.47882691 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.26985438 |
| 7 | MP0009046_muscle_twitch | 3.08681115 |
| 8 | * MP0002064_seizures | 3.08545894 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.92736671 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.92440492 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.73463284 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.57135424 |
| 13 | MP0002272_abnormal_nervous_system | 2.54378644 |
| 14 | MP0003787_abnormal_imprinting | 2.48163842 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.43765187 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.39448880 |
| 17 | MP0001486_abnormal_startle_reflex | 2.39264265 |
| 18 | MP0003195_calcinosis | 2.35774729 |
| 19 | MP0002736_abnormal_nociception_after | 2.32557731 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.21376010 |
| 21 | * MP0002067_abnormal_sensory_capabilities | 1.94508531 |
| 22 | MP0002822_catalepsy | 1.91511669 |
| 23 | MP0003879_abnormal_hair_cell | 1.88130726 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.86722077 |
| 25 | MP0001970_abnormal_pain_threshold | 1.80109709 |
| 26 | MP0001188_hyperpigmentation | 1.79210786 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.71447567 |
| 28 | MP0001502_abnormal_circadian_rhythm | 1.69504458 |
| 29 | MP0005645_abnormal_hypothalamus_physiol | 1.68590599 |
| 30 | MP0006276_abnormal_autonomic_nervous | 1.67939299 |
| 31 | MP0002184_abnormal_innervation | 1.67887118 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.66018856 |
| 33 | MP0000778_abnormal_nervous_system | 1.64964639 |
| 34 | * MP0002557_abnormal_social/conspecific_i | 1.63006576 |
| 35 | MP0003122_maternal_imprinting | 1.60570352 |
| 36 | MP0004924_abnormal_behavior | 1.56147882 |
| 37 | MP0005386_behavior/neurological_phenoty | 1.56147882 |
| 38 | MP0004133_heterotaxia | 1.55320456 |
| 39 | * MP0008569_lethality_at_weaning | 1.51898887 |
| 40 | MP0002163_abnormal_gland_morphology | 1.48244334 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.47708055 |
| 42 | MP0003878_abnormal_ear_physiology | 1.47214580 |
| 43 | MP0005377_hearing/vestibular/ear_phenot | 1.47214580 |
| 44 | MP0005171_absent_coat_pigmentation | 1.46119364 |
| 45 | * MP0001905_abnormal_dopamine_level | 1.45821890 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.45563242 |
| 47 | MP0004858_abnormal_nervous_system | 1.44006706 |
| 48 | MP0001944_abnormal_pancreas_morphology | 1.39151310 |
| 49 | MP0003633_abnormal_nervous_system | 1.33690957 |
| 50 | * MP0002882_abnormal_neuron_morphology | 1.31270741 |
| 51 | MP0002693_abnormal_pancreas_physiology | 1.29762725 |
| 52 | * MP0002066_abnormal_motor_capabilities/c | 1.28979395 |
| 53 | MP0000955_abnormal_spinal_cord | 1.28796580 |
| 54 | MP0001984_abnormal_olfaction | 1.27297879 |
| 55 | MP0005253_abnormal_eye_physiology | 1.26201686 |
| 56 | MP0003329_amyloid_beta_deposits | 1.19730296 |
| 57 | MP0002928_abnormal_bile_duct | 1.16052937 |
| 58 | MP0002876_abnormal_thyroid_physiology | 1.13333614 |
| 59 | MP0004885_abnormal_endolymph | 1.11909168 |
| 60 | MP0008961_abnormal_basal_metabolism | 1.08294926 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.07301170 |
| 62 | * MP0004142_abnormal_muscle_tone | 1.07059991 |
| 63 | MP0003646_muscle_fatigue | 1.06544270 |
| 64 | MP0005409_darkened_coat_color | 1.05968360 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 1.05088819 |
| 66 | MP0010386_abnormal_urinary_bladder | 1.04826070 |
| 67 | * MP0003698_abnormal_male_reproductive | 1.01969842 |
| 68 | * MP0003631_nervous_system_phenotype | 1.00901093 |
| 69 | MP0000427_abnormal_hair_cycle | 0.99788509 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 0.99353805 |
| 71 | MP0001529_abnormal_vocalization | 0.98104258 |
| 72 | MP0008877_abnormal_DNA_methylation | 0.97231294 |
| 73 | MP0004147_increased_porphyrin_level | 0.96931711 |
| 74 | * MP0002152_abnormal_brain_morphology | 0.96004100 |
| 75 | MP0005448_abnormal_energy_balance | 0.94092325 |
| 76 | MP0000569_abnormal_digit_pigmentation | 0.93911599 |
| 77 | MP0001963_abnormal_hearing_physiology | 0.93404263 |
| 78 | MP0000230_abnormal_systemic_arterial | 0.93400008 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.93037706 |
| 80 | MP0002638_abnormal_pupillary_reflex | 0.92753271 |
| 81 | MP0000751_myopathy | 0.91267406 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 0.91059779 |
| 83 | MP0008875_abnormal_xenobiotic_pharmacok | 0.90098947 |
| 84 | MP0002229_neurodegeneration | 0.90089221 |
| 85 | MP0003011_delayed_dark_adaptation | 0.88272051 |
| 86 | MP0002837_dystrophic_cardiac_calcinosis | 0.86803715 |
| 87 | MP0002938_white_spotting | 0.86632247 |
| 88 | * MP0002069_abnormal_eating/drinking_beha | 0.85988526 |
| 89 | MP0000013_abnormal_adipose_tissue | 0.85086214 |
| 90 | * MP0003953_abnormal_hormone_level | 0.84947411 |
| 91 | MP0003137_abnormal_impulse_conducting | 0.84763893 |
| 92 | MP0010329_abnormal_lipoprotein_level | 0.84421940 |
| 93 | MP0002102_abnormal_ear_morphology | 0.83467738 |
| 94 | MP0005174_abnormal_tail_pigmentation | 0.82798112 |
| 95 | MP0005195_abnormal_posterior_eye | 0.81425819 |
| 96 | MP0001485_abnormal_pinna_reflex | 0.81385349 |
| 97 | MP0004085_abnormal_heartbeat | 0.81197992 |
| 98 | MP0008872_abnormal_physiological_respon | 0.81193226 |
| 99 | MP0006292_abnormal_olfactory_placode | 0.80830842 |
| 100 | MP0005535_abnormal_body_temperature | 0.80041351 |
| 101 | MP0005220_abnormal_exocrine_pancreas | 0.79013644 |
| 102 | MP0005410_abnormal_fertilization | 0.78807098 |
| 103 | MP0004742_abnormal_vestibular_system | 0.78542341 |
| 104 | MP0002234_abnormal_pharynx_morphology | 0.76437920 |
| 105 | MP0004043_abnormal_pH_regulation | 0.76114556 |
| 106 | MP0006072_abnormal_retinal_apoptosis | 0.74687709 |
| 107 | MP0000631_abnormal_neuroendocrine_gland | 0.74195838 |
| 108 | * MP0001765_abnormal_ion_homeostasis | 0.73303098 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.72300551 |
| 110 | MP0003075_altered_response_to | 0.71879385 |
| 111 | MP0001664_abnormal_digestion | 0.71360587 |
| 112 | MP0003123_paternal_imprinting | 0.70599568 |
| 113 | MP0008874_decreased_physiological_sensi | 0.69944474 |
| 114 | MP0002752_abnormal_somatic_nervous | 0.67853270 |
| 115 | MP0003121_genomic_imprinting | 0.67349134 |
| 116 | MP0005379_endocrine/exocrine_gland_phen | 0.64513419 |
| 117 | MP0000678_abnormal_parathyroid_gland | 0.64143540 |
| 118 | MP0001177_atelectasis | 0.64063863 |
| 119 | MP0000026_abnormal_inner_ear | 0.61985153 |
| 120 | MP0004484_altered_response_of | 0.60301584 |
| 121 | MP0004215_abnormal_myocardial_fiber | 0.59768826 |
| 122 | MP0003634_abnormal_glial_cell | 0.58898465 |
| 123 | MP0003690_abnormal_glial_cell | 0.57425030 |
| 124 | MP0003283_abnormal_digestive_organ | 0.56858919 |
| 125 | MP0003172_abnormal_lysosome_physiology | 0.55336643 |
| 126 | MP0004510_myositis | 0.54709039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.85421800 |
| 2 | Focal seizures (HP:0007359) | 5.92339811 |
| 3 | Myokymia (HP:0002411) | 5.66522646 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.53459139 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 5.15936485 |
| 6 | Febrile seizures (HP:0002373) | 4.80472134 |
| 7 | Visual hallucinations (HP:0002367) | 4.76064870 |
| 8 | Atonic seizures (HP:0010819) | 4.68466787 |
| 9 | Decreased circulating renin level (HP:0003351) | 4.32796905 |
| 10 | Congenital stationary night blindness (HP:0007642) | 4.31936651 |
| 11 | Dialeptic seizures (HP:0011146) | 4.14377108 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.02078379 |
| 13 | Absence seizures (HP:0002121) | 3.99835368 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 3.89849867 |
| 15 | Hyperventilation (HP:0002883) | 3.66287255 |
| 16 | Amblyopia (HP:0000646) | 3.60489163 |
| 17 | Broad-based gait (HP:0002136) | 3.52808176 |
| 18 | Increased circulating renin level (HP:0000848) | 3.46696590 |
| 19 | Nephronophthisis (HP:0000090) | 3.41757321 |
| 20 | Action tremor (HP:0002345) | 3.39586709 |
| 21 | Pancreatic cysts (HP:0001737) | 3.28767512 |
| 22 | Dysmetria (HP:0001310) | 3.21725444 |
| 23 | Genetic anticipation (HP:0003743) | 3.21314953 |
| 24 | Pancreatic fibrosis (HP:0100732) | 3.20554435 |
| 25 | Abnormality of midbrain morphology (HP:0002418) | 3.16711583 |
| 26 | Molar tooth sign on MRI (HP:0002419) | 3.16711583 |
| 27 | Large for gestational age (HP:0001520) | 3.15570245 |
| 28 | Epileptiform EEG discharges (HP:0011182) | 3.12685929 |
| 29 | Dysdiadochokinesis (HP:0002075) | 3.09292414 |
| 30 | Hyperkalemia (HP:0002153) | 3.05208888 |
| 31 | True hermaphroditism (HP:0010459) | 3.04712354 |
| 32 | Hyperactive renin-angiotensin system (HP:0000841) | 3.04306216 |
| 33 | Attenuation of retinal blood vessels (HP:0007843) | 3.03870960 |
| 34 | Abnormality of the lower motor neuron (HP:0002366) | 3.02279620 |
| 35 | Abnormality of the renal medulla (HP:0100957) | 2.94358346 |
| 36 | Truncal ataxia (HP:0002078) | 2.94293836 |
| 37 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.93777622 |
| 38 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.86754378 |
| 39 | Impaired smooth pursuit (HP:0007772) | 2.84428881 |
| 40 | Drooling (HP:0002307) | 2.79252432 |
| 41 | Excessive salivation (HP:0003781) | 2.79252432 |
| 42 | Hemiparesis (HP:0001269) | 2.75486217 |
| 43 | Hypothermia (HP:0002045) | 2.73768692 |
| 44 | Abnormality of the renal cortex (HP:0011035) | 2.69237798 |
| 45 | Depression (HP:0000716) | 2.68743055 |
| 46 | Severe visual impairment (HP:0001141) | 2.68266006 |
| 47 | Polydipsia (HP:0001959) | 2.66329806 |
| 48 | Abnormal drinking behavior (HP:0030082) | 2.66329806 |
| 49 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.65522057 |
| 50 | Absent/shortened dynein arms (HP:0200106) | 2.65522057 |
| 51 | EEG with generalized epileptiform discharges (HP:0011198) | 2.65113759 |
| 52 | Medial flaring of the eyebrow (HP:0010747) | 2.63042977 |
| 53 | Anxiety (HP:0000739) | 2.60793675 |
| 54 | Supranuclear gaze palsy (HP:0000605) | 2.56919978 |
| 55 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.56322257 |
| 56 | Limb dystonia (HP:0002451) | 2.53128854 |
| 57 | Ankle clonus (HP:0011448) | 2.48709731 |
| 58 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.48178263 |
| 59 | Poor eye contact (HP:0000817) | 2.46932458 |
| 60 | Chronic hepatic failure (HP:0100626) | 2.46572201 |
| 61 | Congenital sensorineural hearing impairment (HP:0008527) | 2.43775684 |
| 62 | Scanning speech (HP:0002168) | 2.43295673 |
| 63 | Blue irides (HP:0000635) | 2.42764000 |
| 64 | Hypsarrhythmia (HP:0002521) | 2.40698679 |
| 65 | Diplopia (HP:0000651) | 2.38986875 |
| 66 | Abnormality of binocular vision (HP:0011514) | 2.38986875 |
| 67 | Abnormality of macular pigmentation (HP:0008002) | 2.38326141 |
| 68 | Abnormal eating behavior (HP:0100738) | 2.38308462 |
| 69 | Protruding tongue (HP:0010808) | 2.38008300 |
| 70 | Postural instability (HP:0002172) | 2.37105003 |
| 71 | Gait imbalance (HP:0002141) | 2.36888910 |
| 72 | Cystic liver disease (HP:0006706) | 2.36744844 |
| 73 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.35397897 |
| 74 | Hypoplasia of the fovea (HP:0007750) | 2.35397897 |
| 75 | Agitation (HP:0000713) | 2.34022487 |
| 76 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.33450675 |
| 77 | Absent speech (HP:0001344) | 2.31763861 |
| 78 | Tubular atrophy (HP:0000092) | 2.29821004 |
| 79 | Ketoacidosis (HP:0001993) | 2.28434903 |
| 80 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.28349458 |
| 81 | Intestinal atresia (HP:0011100) | 2.26833937 |
| 82 | Polyphagia (HP:0002591) | 2.26488184 |
| 83 | Sclerocornea (HP:0000647) | 2.26047735 |
| 84 | Stereotypic behavior (HP:0000733) | 2.23023210 |
| 85 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.22276032 |
| 86 | Impaired social interactions (HP:0000735) | 2.21050302 |
| 87 | Abnormal social behavior (HP:0012433) | 2.21050302 |
| 88 | Abnormality of renin-angiotensin system (HP:0000847) | 2.20042669 |
| 89 | Bradykinesia (HP:0002067) | 2.16345825 |
| 90 | Hypoplastic ischia (HP:0003175) | 2.16135388 |
| 91 | Hemiplegia (HP:0002301) | 2.15385885 |
| 92 | Dysmetric saccades (HP:0000641) | 2.14140337 |
| 93 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.13566279 |
| 94 | Decreased central vision (HP:0007663) | 2.12816063 |
| 95 | Abolished electroretinogram (ERG) (HP:0000550) | 2.10146152 |
| 96 | Abnormal ciliary motility (HP:0012262) | 2.09446732 |
| 97 | Retinal dysplasia (HP:0007973) | 2.06877980 |
| 98 | Pheochromocytoma (HP:0002666) | 2.05469567 |
| 99 | Spastic gait (HP:0002064) | 2.05193310 |
| 100 | Cerebellar dysplasia (HP:0007033) | 2.04811063 |
| 101 | Impaired vibratory sensation (HP:0002495) | 2.04601492 |
| 102 | Hyperaldosteronism (HP:0000859) | 2.04520093 |
| 103 | Polyuria (HP:0000103) | 2.03570863 |
| 104 | Congenital primary aphakia (HP:0007707) | 2.02855773 |
| 105 | Prolonged QT interval (HP:0001657) | 2.01935393 |
| 106 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.00202784 |
| 107 | Status epilepticus (HP:0002133) | 1.99290327 |
| 108 | Severe muscular hypotonia (HP:0006829) | 1.96947917 |
| 109 | Lissencephaly (HP:0001339) | 1.95684999 |
| 110 | Fetal akinesia sequence (HP:0001989) | 1.95295325 |
| 111 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.94481566 |
| 112 | Tubulointerstitial nephritis (HP:0001970) | 1.93883903 |
| 113 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.93812581 |
| 114 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.93812581 |
| 115 | Incomplete penetrance (HP:0003829) | 1.92793478 |
| 116 | Ketosis (HP:0001946) | 1.91674874 |
| 117 | Urinary urgency (HP:0000012) | 1.91035138 |
| 118 | Furrowed tongue (HP:0000221) | 1.90367816 |
| 119 | Abnormality of salivation (HP:0100755) | 1.88848169 |
| 120 | Type II lissencephaly (HP:0007260) | 1.88676760 |
| 121 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.86433345 |
| 122 | Dyskinesia (HP:0100660) | 1.84457136 |
| 123 | Generalized myoclonic seizures (HP:0002123) | 1.83915587 |
| 124 | Pachygyria (HP:0001302) | 1.83598350 |
| 125 | Renal cortical cysts (HP:0000803) | 1.83449307 |
| 126 | Genital tract atresia (HP:0001827) | 1.83218063 |
| 127 | Clumsiness (HP:0002312) | 1.82235490 |
| 128 | Abnormality of the ischium (HP:0003174) | 1.81740588 |
| 129 | Abnormality of the fovea (HP:0000493) | 1.81300944 |
| 130 | Keratoconus (HP:0000563) | 1.80428098 |
| 131 | Increased corneal curvature (HP:0100692) | 1.80428098 |
| 132 | Congenital hepatic fibrosis (HP:0002612) | 1.80311157 |
| 133 | Abnormality of saccadic eye movements (HP:0000570) | 1.80017446 |
| 134 | Gait ataxia (HP:0002066) | 1.79512527 |
| 135 | Nephrogenic diabetes insipidus (HP:0009806) | 1.78917712 |
| 136 | Intention tremor (HP:0002080) | 1.78618101 |
| 137 | Progressive inability to walk (HP:0002505) | 1.77769455 |
| 138 | Toxemia of pregnancy (HP:0100603) | 1.77537045 |
| 139 | Widely spaced teeth (HP:0000687) | 1.74967306 |
| 140 | Focal dystonia (HP:0004373) | 1.74514480 |
| 141 | Optic nerve hypoplasia (HP:0000609) | 1.74090450 |
| 142 | Lower limb amyotrophy (HP:0007210) | 1.73673226 |
| 143 | Vaginal atresia (HP:0000148) | 1.72764054 |
| 144 | Thickened helices (HP:0000391) | 1.71858840 |
| 145 | Confusion (HP:0001289) | 1.70945212 |
| 146 | Neuroendocrine neoplasm (HP:0100634) | 1.70287392 |
| 147 | Bradycardia (HP:0001662) | 1.70065447 |
| 148 | Torticollis (HP:0000473) | 1.69913032 |
| 149 | Hypoventilation (HP:0002791) | 1.69713536 |
| 150 | Ventricular fibrillation (HP:0001663) | 1.69657481 |
| 151 | Psychosis (HP:0000709) | 1.69633988 |
| 152 | Mutism (HP:0002300) | 1.69209390 |
| 153 | Inability to walk (HP:0002540) | 1.68724360 |
| 154 | Generalized hypopigmentation of hair (HP:0011358) | 1.67727662 |
| 155 | Lower limb muscle weakness (HP:0007340) | 1.66323767 |
| 156 | Cerebral inclusion bodies (HP:0100314) | 1.66216871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.23437044 |
| 2 | NTRK3 | 6.23628656 |
| 3 | EPHA4 | 4.23897012 |
| 4 | MAP3K9 | 3.09971771 |
| 5 | TNIK | 3.01339093 |
| 6 | MAP3K4 | 3.00910723 |
| 7 | MAP2K7 | 2.88563765 |
| 8 | CASK | 2.68264056 |
| 9 | ACVR1B | 2.12441718 |
| 10 | DAPK2 | 2.08475661 |
| 11 | BMPR1B | 2.07419252 |
| 12 | MINK1 | 2.05795986 |
| 13 | MARK1 | 2.03065864 |
| 14 | GRK1 | 2.01456945 |
| 15 | PRPF4B | 2.00527752 |
| 16 | MAP4K2 | 1.99653647 |
| 17 | PRKD3 | 1.96152609 |
| 18 | NTRK2 | 1.92727814 |
| 19 | DAPK1 | 1.82632879 |
| 20 | MAP2K4 | 1.77968617 |
| 21 | PAK6 | 1.64956049 |
| 22 | MAPK13 | 1.59058786 |
| 23 | MAP3K12 | 1.58280124 |
| 24 | PLK2 | 1.55360716 |
| 25 | TLK1 | 1.54748528 |
| 26 | KSR1 | 1.45824850 |
| 27 | RIPK4 | 1.45762924 |
| 28 | CAMK2B | 1.43818186 |
| 29 | CDK19 | 1.39048454 |
| 30 | MAP3K13 | 1.38627118 |
| 31 | CDK5 | 1.37488571 |
| 32 | CAMK2A | 1.34596978 |
| 33 | FGFR2 | 1.33287125 |
| 34 | KSR2 | 1.29289351 |
| 35 | FES | 1.24926060 |
| 36 | ZAK | 1.24576021 |
| 37 | GRK5 | 1.22694198 |
| 38 | PTK2B | 1.22558102 |
| 39 | PRKCG | 1.22295386 |
| 40 | MARK2 | 1.21678980 |
| 41 | CAMKK1 | 1.15705694 |
| 42 | NTRK1 | 1.14895045 |
| 43 | UHMK1 | 1.13082887 |
| 44 | AKT3 | 1.11271843 |
| 45 | SIK2 | 1.10750451 |
| 46 | STK38 | 1.09971627 |
| 47 | CSNK1G2 | 1.08637157 |
| 48 | MAPK15 | 1.08046295 |
| 49 | MKNK2 | 1.07820282 |
| 50 | CAMK1 | 1.07205766 |
| 51 | INSRR | 1.05077561 |
| 52 | PNCK | 1.04596741 |
| 53 | WNK3 | 1.04496503 |
| 54 | NME1 | 0.99977739 |
| 55 | CAMKK2 | 0.98812622 |
| 56 | MAP3K2 | 0.96962674 |
| 57 | MUSK | 0.96495308 |
| 58 | SGK223 | 0.95978799 |
| 59 | SGK494 | 0.95978799 |
| 60 | SGK2 | 0.95453387 |
| 61 | ADRBK1 | 0.94068122 |
| 62 | ARAF | 0.92051062 |
| 63 | STK39 | 0.90336786 |
| 64 | TAOK3 | 0.87569201 |
| 65 | CDC42BPA | 0.84782972 |
| 66 | STK38L | 0.84351808 |
| 67 | SGK1 | 0.83782935 |
| 68 | MAP2K6 | 0.83594189 |
| 69 | CAMK2D | 0.79381586 |
| 70 | OXSR1 | 0.78984042 |
| 71 | DYRK2 | 0.78040063 |
| 72 | PAK3 | 0.77267148 |
| 73 | BMPR2 | 0.77049232 |
| 74 | DYRK1A | 0.74593155 |
| 75 | CDK18 | 0.74273133 |
| 76 | CDK15 | 0.72362233 |
| 77 | MAPKAPK5 | 0.71530328 |
| 78 | FER | 0.69585802 |
| 79 | CAMK1D | 0.69568281 |
| 80 | PRKAA1 | 0.69445487 |
| 81 | WNK4 | 0.68943956 |
| 82 | MAPKAPK3 | 0.65779289 |
| 83 | PRKCH | 0.65429128 |
| 84 | TNK2 | 0.65346950 |
| 85 | CDK14 | 0.64469046 |
| 86 | CDK11A | 0.64423603 |
| 87 | MAP3K7 | 0.63941761 |
| 88 | PKN1 | 0.63179134 |
| 89 | SGK3 | 0.63156411 |
| 90 | PRKCE | 0.63091174 |
| 91 | PDK1 | 0.61251409 |
| 92 | CAMK2G | 0.59868704 |
| 93 | NEK6 | 0.59845244 |
| 94 | CSNK1G1 | 0.59335030 |
| 95 | MAP3K6 | 0.58888431 |
| 96 | STK11 | 0.58396335 |
| 97 | PRKAA2 | 0.58276065 |
| 98 | PRKCZ | 0.57473640 |
| 99 | CSNK1G3 | 0.56484666 |
| 100 | SIK3 | 0.56418847 |
| 101 | BRAF | 0.52888326 |
| 102 | RET | 0.51562017 |
| 103 | NUAK1 | 0.48939751 |
| 104 | PDPK1 | 0.48496373 |
| 105 | PINK1 | 0.47815467 |
| 106 | FGR | 0.46821883 |
| 107 | CAMK4 | 0.46704615 |
| 108 | RAF1 | 0.45974475 |
| 109 | RPS6KA3 | 0.45551220 |
| 110 | CAMK1G | 0.43370120 |
| 111 | DMPK | 0.41757262 |
| 112 | TRPM7 | 0.41056457 |
| 113 | PRKG1 | 0.40813237 |
| 114 | PHKG2 | 0.40254104 |
| 115 | PHKG1 | 0.40254104 |
| 116 | WNK1 | 0.40019270 |
| 117 | ADRBK2 | 0.39866492 |
| 118 | CSNK1D | 0.38430717 |
| 119 | MAP3K1 | 0.38167995 |
| 120 | STK3 | 0.37619642 |
| 121 | PRKCA | 0.37280325 |
| 122 | PTK2 | 0.36806440 |
| 123 | CDK3 | 0.36549386 |
| 124 | FYN | 0.36191660 |
| 125 | PRKACA | 0.34468612 |
| 126 | TYRO3 | 0.34468153 |
| 127 | PRKACB | 0.33414895 |
| 128 | CSNK1A1L | 0.32892306 |
| 129 | CSNK1A1 | 0.32608058 |
| 130 | PRKCB | 0.32360891 |
| 131 | CSNK1E | 0.32297825 |
| 132 | CCNB1 | 0.32093490 |
| 133 | ERBB3 | 0.31778292 |
| 134 | CHUK | 0.28933526 |
| 135 | TIE1 | 0.27017839 |
| 136 | GSK3B | 0.26355047 |
| 137 | MAP2K1 | 0.25960373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.40575863 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.28977658 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.16758700 |
| 4 | * Circadian entrainment_Homo sapiens_hsa04713 | 3.08161883 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.97175268 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.91050787 |
| 7 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.90604242 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.89152602 |
| 9 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.52842048 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.51896008 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.43886004 |
| 12 | * Morphine addiction_Homo sapiens_hsa05032 | 2.42187405 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.36603276 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 2.32842490 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 2.19127486 |
| 16 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.17657815 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.07837145 |
| 18 | Cocaine addiction_Homo sapiens_hsa05030 | 2.05313885 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 2.04360240 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.99378874 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.92932468 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.89355782 |
| 23 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.87517440 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.84285399 |
| 25 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.78624353 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.70057098 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.66977754 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.65766270 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.65561397 |
| 30 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.65046715 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.61058126 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.49643859 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.49236911 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.48702410 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.48419531 |
| 36 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.47721620 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.46488938 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.43374313 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.39821430 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.39038733 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.36757210 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.24314457 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.24189261 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.19326472 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.16798228 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16591260 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.15956904 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.14002193 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 1.13773070 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.12888222 |
| 51 | Circadian rhythm_Homo sapiens_hsa04710 | 1.09396640 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 1.09327973 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03597325 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01229055 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97106146 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97086963 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.96765549 |
| 58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96701236 |
| 59 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94728362 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92980453 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92962086 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.89567034 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88675631 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87400313 |
| 65 | Phototransduction_Homo sapiens_hsa04744 | 0.85006082 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.84557606 |
| 67 | Protein export_Homo sapiens_hsa03060 | 0.82228272 |
| 68 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78667434 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77645243 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74560295 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74460321 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72974099 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72496523 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72050078 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71877146 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71829539 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70862261 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68915233 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68900330 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68674294 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68056778 |
| 82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67837937 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67186332 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66983480 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65237067 |
| 86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64687114 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62849945 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.59992228 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59360153 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58548146 |
| 91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56932821 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.56414638 |
| 93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56059833 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55046772 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52900145 |
| 96 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51977616 |
| 97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50508091 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50144542 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47845156 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47799817 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47552283 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46064467 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45779978 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45600989 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45539015 |
| 106 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45209502 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44048651 |
| 108 | Alcoholism_Homo sapiens_hsa05034 | 0.42744593 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42676135 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41627563 |
| 111 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39741443 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38995422 |
| 113 | Huntingtons disease_Homo sapiens_hsa05016 | 0.38833843 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38117138 |
| 115 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37637490 |
| 116 | Bile secretion_Homo sapiens_hsa04976 | 0.35596009 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.34784593 |
| 118 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.34026477 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32860183 |
| 120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.32521841 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32370942 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30885580 |
| 123 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30232664 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29597155 |
| 125 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.29477135 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.26633807 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.25736069 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25093193 |
| 129 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.24057133 |
| 130 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22269295 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.21045258 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.19898093 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.19468301 |
| 134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.18801684 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17502669 |
| 136 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.17326571 |
| 137 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.15688572 |
| 138 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.14599874 |

